Lund Arthritis Research Group (LARG)
1 – 10 of 106
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2025
-
Mark
Four-year secukinumab treatment outcomes in European real-world patients with axial spondyloarthritis and psoriatic arthritis
(
- Contribution to journal › Article
-
Mark
Differences in the response to TNF inhibitors at distinct joint locations in patients with psoriatic arthritis : results from nine European registries
(
- Contribution to journal › Article
-
Mark
Biological material for biomarker research in spondyloarthritis : mapping the availability in European rheumatology registries
(
- Contribution to journal › Letter
-
Mark
Incidence of Clinically Diagnosed Psoriatic Arthritis in Sweden
(
- Contribution to journal › Article
-
Mark
Work loss in patients with rheumatoid arthritis treated with abatacept, rituximab, tocilizumab or TNF inhibitors : a nationwide direct drug-to-drug comparison
(
- Contribution to journal › Article
-
Mark
Handling of missing component information for common composite score outcomes used in axial spondyloarthritis research when complete-case analysis is unbiased
(
- Contribution to journal › Article
-
Mark
Musculoskeletal diseases, infections and vaccines : state of the art, research perspectives and educational needs
(
- Contribution to journal › Scientific review
-
Mark
Challenge of missing data in observational studies : investigating cross-sectional imputation methods for assessing disease activity in axial spondyloarthritis
(
- Contribution to journal › Article
- 2024
-
Mark
Joint tenderness at 3 months follow-up better predicts long-term pain than baseline characteristics in early rheumatoid arthritis patients
(
- Contribution to journal › Article
-
Mark
Second and third TNF inhibitors in European patients with axial spondyloarthritis : effectiveness and impact of the reason for switching
(
- Contribution to journal › Article